Galanthamine derivatives as acetylcholinesterase inhibitors

Details Galanthamine derivatives as acetylcholinesterase inhibitors Galanthamine derivatives as acetylcholinesterase inhibitors

1995-05-22

1998-07-07

Berch, Mark L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C07D49106, C07B 4104

Patent

active

057771081

ABSTRACT:
This application relates to compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are defined within, which compounds are useful for the treatment of memory dysfunction characterized by decreased cholinergic function, pharmaceutical compositions containing the compounds and methods for making and using the compounds.

REFERENCES:
Harvey, Pharmac. Ther. 68, 113 (1995).
Han, European J. Med. Chem 27, 673(1992).
Bores, Drugs of the Future 21, 621(1996).
Green, "Protective Groups in Organic Synthesis", 2nd Ed. (1991) p. 186.
FDC Report (Pink Sheet) Sep. 30, 1996, p. 9.
Script #2028, May 26, 1996, p. 27.
Koft, Tetrahedron 43, 5775 (1987).
Feutrill, Tet. Letters 1970, p. 1327.
Feutrill, Aus. J. Chem. 25, 1719(1972).
Kendo, J. Org. Chem 50, 727(1985).
Hoffman, J. Org. Chem. 56, 2081 (1991).
Majetich Tetrahedron Letters 34, 445 (1993).
Smith, Tetrahedron Letters 36, 4283 (1985).

Affiliated with

Also associated with

Rating

Galanthamine derivatives as acetylcholinesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galanthamine derivatives as acetylcholinesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galanthamine derivatives as acetylcholinesterase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1207353